BARRETT’S OESOPHAGUS TREATMENT OPTIONS REFLUX TESTING AND TREATMENT
A combination of options, including symptom surveillance and radiofrequency ablation therapy may be used to manage and treat Barrett’s oesophagus.
You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
A combination of options, including symptom surveillance and radiofrequency ablation therapy may be used to manage and treat Barrett’s oesophagus.
Untreated Barrett’s may lead to oesophageal adenocarcinoma, a type of oesophageal cancer, so early detection and treatment is critical. If you have been diagnosed with Barrett’s oesophagus, ask your doctor about available treatment options.
Disease management options for Barrett’s oesophagus vary by progression of precancerous cell growth (dysplasia) in your oesophagus. Speak to a gastroenterologist (GI) about your disease management options.
If you're in the early stages of Barrett's and have no significant risk factors for progression, your physician may recommend periodic appointments to monitor your disease. At these appointments, they will perform an endoscopy and take samples (biopsies) of the affected tissue. The frequency of surveillance may vary depending on the severity of your Barrett's oesophagus and your risk factors.
Radiofrequency ablation (RFA) uses heat to remove precancerous tissue from the oesophagus. Barrett’s oesophagus patients treated with radiofrequency ablation are less likely to progress to oesophageal cancer compared to patients who undergo surveillance. The Barrx™ radiofrequency ablation system can reduce the relative risk of disease progression to cancer by up to 94 percent.1-3
Depending on the stage of your Barrett's oesophagus, your doctor will likely recommend surveillance, or endoscopic therapy such as radiofrequency ablation, argon plasma coagulation, cryotherapy, endoscopic mucosal resection, or endoscopic submucosal dissection.
Find a hospital in your area who specialises in diagnosing and treating Barrett's oesophagus.
SEARCH NOWInformation and resources on this site should not be used as a substitute for medical advice from your doctor. Always discuss diagnosis and treatment information including risks with your doctor. Keep in mind that all treatment and outcome results are specific to the individual patient. Results may vary.
Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009;360:2277-88
Phoa KN, van Vilsteren FG, Pouw RE, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014 Mar 26;311(12):1209-17
Wolf WA, Pasricha S, Cotton C, et al. Incidence of Esophageal Adenocarcinoma and Causes of Mortality after Radiofrequency Ablation of Barrett's esophagus. Gastroenterology. 2015;149:1752-1761